LUPIN Financials

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:3em;padding-top: 38px;;'>LUP</div>
Understanding current and past LUPIN Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We recommend to make use of LUPIN LTD fundamental analysis to find out if markets are currently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of LUPIN LTD as well as the relationship between them. We were able to interpolate thirty-three available fundamentals for LUPIN, which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all LUPIN LTD financials, including its net income and the relationship between the current ratio and current asset .

Search Fundamentals

 
Refresh
With this module, you can analyze LUPIN financials for your investing period. You should be able to track the changes in LUPIN individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
35%35%

Chance of Financial Distress

LUPIN LTD has less than 35 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for LUPIN stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info

LUPIN Company Summary

Lupin Limited, a pharmaceutical company, develops, produces, and markets a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients worldwide. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India. LUPIN LTD operates under Drug Manufacturers - Specialty Generic classification in India and is traded on Bombay Stock Exchange. It employs 17684 people.
InstrumentIndia Stock View All
ExchangeBombay Stock Exchange
Business AddressB4 Laxmi Towers
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.lupin.com
Phone91 22 6640 2222
CurrencyINR

LUPIN Key Financial Ratios

LUPIN Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LUPIN's current stock value. Our valuation model uses many indicators to compare LUPIN value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LUPIN competition to find correlations between indicators driving LUPIN's intrinsic value. More Info.
LUPIN LTD is currently regarded as number one stock in operating margin category among related companies. It is currently regarded as number one stock in beta category among related companies totaling about  0.05  of Beta per Operating Margin. The ratio of Operating Margin to Beta for LUPIN LTD is roughly  21.08 

LUPIN Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Stocks Correlation. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page